tiprankstipranks
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC

Cyclacel Pharmaceuticals (CYCC) Financial Statements

605 Followers

Cyclacel Pharmaceuticals Financial Overview

Cyclacel Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-27.019; its P/E ratio is -0.07; Cyclacel Pharmaceuticals is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-5.24. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 16.00K$ 373.00K--$ 0.00
Gross Profit$ 16.00K$ 373.00K---
EBIT$ -6.70M$ -6.03M$ -7.12M$ -9.12M$ -6.47M
EBITDA$ -6.69M$ -6.03M$ -7.12M$ -9.11M$ -6.46M
Net Income Common Stockholders$ -6.08M$ -5.50M$ -5.85M$ -7.47M$ -5.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.94M$ 10.16M$ 11.44M$ 18.34M$ 23.71M
Total Assets$ 12.50M$ 16.44M$ 22.03M$ 27.50M$ 31.02M
Total Debt$ 52.00K$ 66.00K$ 80.00K$ 106.00K$ 107.00K
Net Debt$ -5.89M$ -10.10M$ -11.36M$ -18.24M$ -23.60M
Total Liabilities$ 8.20M$ 6.81M$ 7.42M$ 7.50M$ 4.46M
Stockholders Equity$ 4.30M$ 5.14M$ 10.15M$ 15.51M$ 26.56M
Cash Flow-
Free Cash Flow$ -4.04M$ -1.30M$ -6.87M$ -5.17M$ -6.97M
Operating Cash Flow$ -4.04M$ -1.30M$ -6.86M$ -5.17M$ -6.97M
Investing Cash Flow--$ -6.00K-$ 0.00
Financing Cash Flow$ -50.00K$ -51.00K$ -50.00K$ 42.00K$ 1.53M
Currency in USD

Cyclacel Pharmaceuticals Earnings and Revenue History

Cyclacel Pharmaceuticals Debt to Assets

Cyclacel Pharmaceuticals Cash Flow

Cyclacel Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis